Oculis Holding AG
Related Filers (6)
- Novartis Bioventures Ltd (2)
- Pivotal bioVenture Partners Fund I, L.P. (2)
- European Biotech Acquisition Corp. (1)
- BVCF IV, L.P. (1)
- Brunnur vaxtarsjodur slhf (1)
- LSP 7 Cooperative UA (1)
- Show More ...
Other (37)
6-K
Wednesday, 11/15/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/29/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Wednesday, 5/31/2023
Notice of Effectiveness
CORRESP
Tuesday, 5/30/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 5/30/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Tuesday, 5/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-1
Tuesday, 5/30/2023
Registration statement for securities of certain foreign private issuers
6-K
Tuesday, 5/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Monday, 5/1/2023
Notice of Effectiveness
CORRESP
Thursday, 4/27/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 4/20/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Thursday, 4/20/2023
Registration statement for securities of certain foreign private issuers
6-K
Friday, 4/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-1
Monday, 4/3/2023
Registration statement for securities of certain foreign private issuers
20-F
Tuesday, 3/28/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
20-F
Wednesday, 3/8/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Friday, 3/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CERT
Thursday, 3/2/2023
Certification by an exchange approving securities for listing
8-A12B
Wednesday, 3/1/2023
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
SEC STAFF LETTER
Tuesday, 2/14/2023
None
EFFECT
Friday, 2/3/2023
Notice of Effectiveness
CORRESP
Thursday, 2/2/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 2/1/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-4/A
Wednesday, 2/1/2023
Registration statement for securities issued by foreign private issuers in certain business combination transactions
CORRESP
Friday, 1/27/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-4/A
Friday, 1/27/2023
Registration statement for securities issued by foreign private issuers in certain business combination transactions
CORRESP
Friday, 1/6/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-4/A
Friday, 1/6/2023
Registration statement for securities issued by foreign private issuers in certain business combination transactions
CORRESP
Monday, 12/12/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-4/A
Monday, 12/12/2022
Registration statement for securities issued by foreign private issuers in certain business combination transactions
SEC STAFF LETTER
Friday, 12/2/2022
None
F-4
Monday, 11/7/2022
Registration statement for securities issued by foreign private issuers in certain business combination transactions
Ownership (7)
SC 13G/A
Tuesday, 2/13/2024
Novartis Bioventures Ltd: Major Shareholders
SC 13G/A
Monday, 2/12/2024
Pivotal bioVenture Partners Fund I, L.P.: Major Shareholders
SC 13G
Friday, 2/9/2024
LSP 7 Cooperative UA: Major Shareholders
SC 13G
Thursday, 5/4/2023
Brunnur vaxtarsjodur slhf: Major Shareholders
SC 13G
Tuesday, 5/2/2023
BVCF IV, L.P.: Major Shareholders
SC 13G
Wednesday, 3/15/2023
Pivotal bioVenture Partners Fund I, L.P.: Major Shareholders
SC 13G
Monday, 3/13/2023
Novartis Bioventures Ltd: Major Shareholders
Prospectus (11)
424B3
Wednesday, 11/15/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Wednesday, 8/30/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Tuesday, 8/8/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Tuesday, 6/13/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Wednesday, 6/7/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B4
Friday, 6/2/2023
Prospectus filed pursuant to Rule 424(b)(4)
424B3
Wednesday, 5/24/2023
Prospectus filed pursuant to Rule 424(b)(3)
S-8
Monday, 5/15/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
DRS
Wednesday, 5/10/2023
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
424B3
Monday, 5/1/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Friday, 2/3/2023
Prospectus filed pursuant to Rule 424(b)(3)